Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tatiana D’Angelo
Observed names:
T. D'Angelo,
Tatiana D'Angelo,
Tatiana D'angelo
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0001-7807-761X
Observed ORCID:
0009-0001-7807-761X
OpenAlex ID:
A5011196958
PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives
2022
·
Paola Fuso
, Margherita Muratore
, et al.
·
Cancers
·
60
PDF
BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
2022
·
Francesco Pavese
, Ettore Domenico Capoluongo
, et al.
·
Cancers
·
51
PDF
Biomarkers of response to advanced prostate cancer therapy
2020
·
Roberto Iacovelli
, Chiara Ciccarese
, et al.
·
Expert Review of Molecular Diagnostics
·
27
Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer
2022
·
Luisa Carbognin
, Cristina Accetta
, et al.
·
Current Oncology
·
21
PDF
Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine
2023
·
Elisa De Paolis
, Ida Paris
, et al.
·
Frontiers in Oncology
·
11
PDF
The Gut Microbiota in Perimenopausal Anxiety: A Novel Therapeutic Pathway Through Diet
2026
·
Giuseppe Marano
, Claudia d’Abate
, et al.
·
Nutrients
·
7
PDF
Modern Personalized Strategies for Breast Cancer Treatment: Bridging Precision Oncology and Psycho-Oncology
2026
·
Giuseppe Marano
, Ida Paris
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Tolerability and Preliminary Outcomes of Adjuvant T-DM1 in HER2-Positive Breast Cancer After Neoadjuvant Therapy: The ATD Study
2024
·
Eriseld Krasniqi
, Lorena Filomeno
, et al.
·
Cancers
·
4
PDF
Efficacy of VEGFR-TKI plus immune checkpoint inhibitor (ICI) in metastatic renal cell carcinoma (mRCC) patients with favorable IMDC prognosis.
2021
·
Chiara Ciccarese
, Roberto Iacovelli
, et al.
·
Journal of Clinical Oncology
·
3
Insomnia in Breast Cancer: A Neglected Symptom Cluster
2026
·
Giuseppe Marano
, Ida Paris
, et al.
·
Journal of Clinical Medicine
·
2
Time Toxicity in Advanced Breast Cancer: Psychological Burden, Psychiatric Vulnerability, and Implications for Patient-Centered Decision-Making
2026
·
Giuseppe Marano
, Ida Paris
, et al.
·
Medicina
·
1
From detection to full characterization: a germline whole-gene deletion of BRCA1 in a patient with breast cancer illustrating evolving molecular diagnostic approaches in genomics
2026
·
Maria De Bonis
, Marco Fabiani
, et al.
·
Research Square
PDF
Sliding Doors in BRCA2-mutated Invasive Lobular Breast Cancer: the Clinical Value of Comprehensive Liquid Biopsy Profiling
2026
·
Alessia Perrucci
, Ida Paris
, et al.
·
The Journal of Liquid Biopsy
PDF
Double burden of cancer and bipolar disorder: Implications for mental health care
2026
·
Giuseppe Marano
, Antonio Sottile
, et al.
·
World Journal of Psychiatry
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review
2026
·
Sabrina Chiloiro
, Simone Antonio De Sanctis
, et al.
·
Reviews in Endocrine and Metabolic Disorders
PDF
Platinum-based neoadjuvant chemotherapy and the predictive role of DNA damage response biomarkers in TNBC: the NeoCarbo study
2026
·
Eriseld Krasniqi
, Anna Di Benedetto
, et al.
·
npj Breast Cancer
PDF
16P Trastuzumab deruxtecan (T-Dxd) in metastatic HER2-positive breast cancer: Early circulating tumor DNA (ctDNA) responses detected by comprehensive genomic profiling
2026
·
A. Fabi
, E. De Paolis
, et al.
·
ESMO Open
PDF
Abstract PS4-03-22: High throughput analysis in locally advanced triple negative breast cancer TNBC: pathological complete response pCR and mutational status
2026
·
I. Paris
, G. Mantini
, et al.
·
Clinical Cancer Research
Abstract PO4-01-02: High throughput analysis in HER2 positive locally advanced breast cancer: pCR and mutational status
2024
·
Ida Paris
, Angelo Minucci
, et al.
·
Cancer Research
Show more works
View as search
Works count:
19
Citation count:
192
H-index:
6
I10-index:
5
Year
Topic
Type